Material Topics
Material Topics
Bora Pharmaceuticals values the interests of all stakeholders and strives to establish an open, transparent, and with effective communication channels. Through internal discussions and external expert assistance, and referencing the GRI Standards published by the Global Reporting Initiative (GRI) and important industry trends, we systematically identify stakeholders’ sustainability concerns through departmental interviews and questionnaires.
Material Topics Identification
The matrix below shows “impact on internal operations” on the X-axis, “impact on external economic, environmental, and social aspects” on the Y-axis, and bubble size representing “stakeholder concern.” Material Topics are evaluated and identified based on scores, classified into major and general topics. In 2023, seven major topics were identified: supply chain management, drug quality and safety, customer relationship management, talent development and happy workplace, occupational safety and health, human rights protection, and climate change response, serving as the basis for report disclosures and continuous improvement.
Material Topics and Management Guidelines
In 2023, Bora Pharmaceuticals identified seven major topics through sustainable risk assessment processes. The relevant descriptions are as follows: